Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

SHA:688298 Revenue

Zhejiang Orient Gene Biotech had revenue of 256.26M CNY in the quarter ending March 31, 2026, with 33.50% growth. This brings the company's revenue in the last twelve months to 1.01B, up 20.88% year-over-year. In the year 2025, Zhejiang Orient Gene Biotech had annual revenue of 947.38M with 14.43% growth.

• Revenue (ttm): 1.01B
• Revenue Growth: +20.88%
• P/S Ratio: 4.16
• Revenue / Employee: 444.50K
• Employees: 2,434
• Market Cap: 4.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	947.38M	119.46M	14.43%
Dec 31, 2024	827.92M	7.76M	0.95%
Dec 31, 2023	820.16M	-7.95B	-90.65%
Dec 31, 2022	8.77B	-1.40B	-13.78%
Dec 31, 2021	10.17B	6.90B	211.43%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error